Isidro Ferrer Abizanda

Title: Isidro Ferrer Abizanda: Innovator in Molecular Diagnostics

Introduction

Isidro Ferrer Abizanda is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of molecular diagnostics, particularly in relation to dementia with Lewy bodies. His innovative work has the potential to improve the diagnosis and treatment of this complex condition.

Latest Patents

Isidro holds a patent for a molecular diagnostic method specifically designed for dementia with Lewy bodies. This invention describes methods of molecular diagnosis of a specific form of alpha-synucleinopathy, which is associated with the levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) or the alteration of its ubiquityl-ligase activity. The patent also refers to the use of compounds that can modify UCH-L1 levels or its enzymatic activity. This invention has significant applications in diagnosing and treating patients suffering from dementia with Lewy bodies.

Career Highlights

Isidro is currently associated with Oryzon Genomics S.A., a company that focuses on innovative solutions in genomics and molecular diagnostics. His work at Oryzon has allowed him to contribute to advancements in the understanding and treatment of neurodegenerative diseases.

Collaborations

Isidro collaborates with talented professionals in his field, including Tamara Maes and Carlos Buesa Arjol. Their combined expertise enhances the research and development efforts at Oryzon Genomics.

Conclusion

Isidro Ferrer Abizanda is a pioneering inventor whose work in molecular diagnostics is paving the way for better understanding and treatment of dementia with Lewy bodies. His contributions are vital in the ongoing fight against neurodegenerative diseases.